Background illustration for clinical trials search

Paid Clinical Trials Tennessee

Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: St. John's, Scarborough ME, Boston MA, Providence RI,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase3, Recruiting

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

for
Aortoiliac Occlusive Disease
Location: New York NY, New Brunswick NJ, Camden NJ,
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18 - 70+

Code: NCT06872905

Recruiting

A Study of ZL-1310 in Participants With Selected Solid Tumors

for
Solid Tumors
Location: New York NY, Philadelphia PA, Norfolk VA, Fairfax VA,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06885281

Phase1, Phase2, Recruiting

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

for
Psoriatic Arthritis
Location: Hagerstown MD, Plantation FL, Hialeah FL,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07286058

Phase3, Recruiting

Study With Phage for CF Subjects With Pseudomonas Lung Infection

for
Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)
Location: Hawthorne NY, New York NY, New Brunswick NJ, Orlando FL,
Sponsor: BiomX Ltd

Sex: All

Age: 18+

Code: NCT06998043

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Rehabilitation With Empowered STrategies to Optimize REcovery

for
Lumbar Spine Degenerative Changes, Lumbar Spine Surgery
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18 - 70+

Code: NCT07406997

Recruiting

Pelacarsen Roll-over Extension Program

for
Atherosclerotic Cardiovascular Disease
Location: Richmond Hill NY, Summit NJ, New Brunswick NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06875973

Phase3, Recruiting

VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)

for
Critical Illness, Intensive Care Medicine
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT06923462

Recruiting

A Study of Time-Restricted Eating in Childhood Cancer Survivors

for
Childhood Cancer Survivors
Location: New York NY, Memphis TN
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07009288

Recruiting

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Springfield MA, Westbury NY, New York NY, Bloomfield NJ,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT07064759

Phase3, Recruiting

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

for
Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases
Location: Togus ME, Boston MA, Providence RI, New Haven CT,
Sponsor: Duke University

Sex: All

Age: 70+

Code: NCT04262206

Recruiting

TrialNet Pathway to Prevention of T1D

for
Diabetes Mellitus, Type 1
Location: Boston MA, New Haven CT, New York NY, Toronto,
Sponsor: University of South Florida

Sex: All

Age: 2 - 45

Code: NCT00097292

Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: Moncton, Westbury NY, Jamaica NY, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase3, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Boston MA, Westbury NY, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase2, Recruiting

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer,
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07020221

Phase1, Phase2, Recruiting

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis
Location: Worcester MA, New York NY, Boca Raton FL, Maitland FL,
Sponsor: Zenas BioPharma (USA), LLC

Sex: All

Age: 18 - 60

Code: NCT07299019

Phase3, Recruiting

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Willow Grove PA, Richmond VA, Fairfax VA, Rochester NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06769698

Phase2, Recruiting

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

for
Breast Cancer, Triple Negative Breast Cancer, Residual Cancer,
Location: Boston MA, Philadelphia PA, Nashville TN,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04434040

Phase2, Recruiting

Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring

for
Kidney Transplant Rejection, Cell-free DNA
Location: Jacksonville FL, Tampa FL, Cleveland OH, Nashville TN,
Sponsor: Insight Molecular Diagnostics

Sex: All

Age: 18+

Code: NCT07060716

Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Foxborough MA, Burlington MA, Levis, Teaneck NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase3, Recruiting

Popular cities in Tennessee

MurfreesboroChattanoogaKnoxvilleNashvilleMemphis